Real-time enrollment status for this primary biliary cholangitis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:31 AM UTC
| NCT Number | NCT05050136 |
| Recruiting Status | Recruiting |
| Condition | Primary Biliary Cholangitis |
| Phase | PHASE2 |
| Target Enrollment | 260 participants |
| Active Locations | 44 sites in the US |
| Sponsor | Mirum Pharmaceuticals, Inc. |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of July 18, 2026: Clinical trial NCT05050136 is currently recruiting participants. This phase2 study for primary biliary cholangitis is actively seeking new participants at 44 locations across the United States. The study is sponsored by Mirum Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05050136 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05050136 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.